ATLANTA, Oct. 17, 2017 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading medical device and tissue processing company
focused on cardiac and vascular surgery, announced today that 2017
third quarter financial results will be released on Monday, October 30, 2017 after the market
closes. On Tuesday, October 31,
2017, the Company will hold a teleconference call and live
webcast at 8:00 a.m. ET to discuss
the results, followed by a question and answer session hosted by
Pat Mackin, Chairman, President and
Chief Executive Officer of CryoLife, Inc.
To listen to the live teleconference, please dial 201-689-8261 a
few minutes prior to 8:00 a.m. A replay of the teleconference
will be available October 31 through
November 7 and can be accessed by calling (toll free)
877-660-6853 or 201-612-7415. The conference number for the
replay is 13672507.
The live webcast and replay can be accessed by going to the
Investor Relations section of the CryoLife website at
www.cryolife.com and selecting the heading Webcasts &
Presentations. In addition, a copy of the earnings press
release, which will contain financial and statistical information
for the completed quarter, can be accessed on the Investor
Relations section of the CryoLife website.
About CryoLife, Inc.
Headquartered in suburban Atlanta,
Georgia, CryoLife is a leader in the manufacturing,
processing, and distribution of medical devices and implantable
living tissues used in cardiac and vascular surgical
procedures. CryoLife markets and sells products in more than
80 countries worldwide. For additional information about
CryoLife, visit our website, www.cryolife.com.
Contacts:
|
|
|
|
CryoLife
D. Ashley
Lee
Executive Vice
President, Chief Financial Officer
and Chief Operating Officer
Phone: 770-419-3355
|
The Ruth
Group
Zack Kubow
646-536-7020
zkubow@theruthgroup.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/cryolife-announces-release-date-and-teleconference-call-details-for-2017-third-quarter-financial-results-300538370.html
SOURCE CryoLife, Inc.